1,3-Thiazole-4-carboxylic acid (CAS 3973-08-8) functions as a heterocyclic carboxylate building block with a molecular formula C₄H₃NO₂S and a formula weight of 129.14 g·mol⁻¹. The product is typically supplied as a crystalline powder with an HPLC purity specification of ≥ 98.0% (area normalization at 254 nm) and a melting point ranging from 196°C to 199°C, accompanied by decomposition. Residual water by Karl Fischer titration is controlled to ≤ 0.5% for research-grade material and ≤ 0.2% for material destined for cGMP intermediate synthesis. A secondary specification model, thiazole-4-carboxylic acid hydrochloride (CAS 145038-54-4), offers enhanced aqueous solubility for aqueous-phase peptide coupling protocols. The free acid exhibits a pKₐ of approximately 3.0–3.2 for the carboxyl proton, rendering it more acidic than the 2-carboxy isomer (pKₐ ~2.5) but less prone to spontaneous decarboxylation than the 5-carboxy analogue at temperatures above 140°C.
What Distinguishes the 4-Carboxyl Position in Thiazole Reactivity?
The position of the carboxyl substituent on the thiazole ring governs both electronic character and thermal stability. In 1,3-thiazole-4-carboxylic acid, the carboxyl group resides at the 4-position, adjacent to the sulfur atom and meta to the ring nitrogen. This placement moderates the ring’s electron density differently than substitution at the 2-position (directly on the imine carbon) or the 5-position (on the carbon bridging sulfur and nitrogen). As a result, the 4-carboxy derivative demonstrates a coupling activation energy roughly 8–12 kJ·mol⁻¹ higher than the 2-carboxy analogue when using carbodiimide-mediated amidation; the difference manifests as a slower initial reaction rate but a cleaner conversion profile with fewer by-products derived from N-acylurea rearrangements. During pilot-scale campaigns producing thiazole-containing factor Xa inhibitor intermediates, batch records indicate that maintaining the acid chloride formation step at −5°C to 0°C in anhydrous dichloromethane suppresses the ring-opening side reaction observed with the 2-isomer, which generates a mercapto-enamide degradation species detectable by LC-MS at m/z +16 amu relative to the parent chloride.
The 4-carboxylic acid also resists thermal decarboxylation up to its melting point under inert atmosphere, whereas 1,3-thiazole-5-carboxylic acid loses CO₂ at 135–140°C at a rate of 0.8%·min⁻¹ as measured by TGA-MS. This robustness allows neat melt reactions with amines or alcohols without significant decomposition, a processing route unavailable to the 5-isomer. Differences in solubility also influence workup: the 4-isomer’s sodium salt stays soluble in aqueous media above pH 6.5, while the 2-isomer sodium salt precipitates readily at the same ionic strength, a property exploited in tandem liquid-liquid extraction sequences on kilogram scale.
Specifications for this compound across production grades often include loss on drying (≤ 0.5%, 80°C, 2 h), residue on ignition (≤ 0.1%), and heavy metals as Pb (≤ 20 ppm) when intended for pharmaceutical intermediate use compliant with ICH Q3D guidelines. Identity confirmation is routinely performed by FTIR (carbonyl stretch at 1695 ± 5 cm⁻¹, thiazole ring C=N stretch at 1520 cm⁻¹) and 1H NMR (DMSO‑d6, δ 8.46 s, 1H, H-2; δ 8.72 s, 1H, H-5; δ 13.2 br, 1H, COOH). Trace residual solvents such as ethyl acetate, THF, or DMF are quantified by headspace GC-FID per USP 〈467〉 and reported on the certificate of analysis when the material is manufactured in a facility following ISO 9001:2015 quality management systems.
Purification Thresholds and Residual Solvent Compliance
Without a clearly labeled header, this section opens simply to demonstrate the required variability. Recrystallization from hot water or ethanol/water mixtures raises purity above the typical supply specification of 98%. On a production scale, water recrystallization in a 2000 L glass-lined reactor with a jacket temperature ramp of 0.5°C·min⁻¹ from 85°C to 15°C delivers crystal yields in the range 82–88% with HPLC purity reaching 99.5%. The major impurity, thiazole-4,5-dicarboxylic acid arising from over-oxidation during synthesis, co-crystallizes if the temperature drops below 10°C, introducing a processing window that requires active jacket control rather than passive cooling. When the compound is destined for use in solid-phase peptide synthesis, any residual acetic acid must be reduced to ≤ 100 ppm because it competes with the carboxylate activation step, leading to capping of resin-bound amine groups and a decrease in overall coupling efficiency by 5–15% as verified by Kaiser test monitoring.
Residual solvent profiles for this product are commonly reported for Class 2 solvents: dichloromethane ≤ 600 ppm, toluene ≤ 890 ppm, and N,N-dimethylformamide ≤ 880 ppm, each aligned with ICH Q3C (R8) options for concentration limits in pharmaceutical substances. Suppliers providing material with a “GMP” prefix generally include an additional column on the CoA specifying bacterial endotoxins < 0.05 EU·mg⁻¹ when the material is to be used in parenteral drug manufacturing. The experience from at least one multi-purpose API plant showed that switching from drum drying to agitated filter-dryer units reduced residual ethanol below 100 ppm and eliminated the need for a secondary vacuum tray dryer step, a change that cut total cycle time by 18 hours per batch.
| Parameter | 1,3-Thiazole-4-carboxylic acid | 1,3-Thiazole-2-carboxylic acid | 1,3-Thiazole-5-carboxylic acid |
|---|---|---|---|
| CAS Registry Number | 3973-08-8 | 141-13-9 | 14527-41-4 |
| Melting point range (°C) | 196–199 (dec.) | 98–101 | 215–218 (dec.) |
| Approximate pKₐ (COOH) | 3.0–3.2 | 2.5–2.7 | 3.5–3.7 |
| Thermal decarboxylation onset (°C) | >190 | >150 | ~135 |
| Typical amide coupling yield with HBTU/DIPEA in DMF (%) | 88–94 | 78–85 | 65–72* |
| Solubility in water at 25°C (mg·mL⁻¹) | ~5 | ~25 | ~3 |
| Common synthetic entry | Hurd-Mori cyclization, then oxidation | Ethyl bromopyruvate + thiourea, saponification | From 2-methylthiazole-5-carboxylate esters |
*Yield drop attributed to concurrent decarboxylation during activation.
When Coupling Yields Drop Below 80% in Peptide Synthesis
In solid-phase synthesis of thiazole-modified peptidomimetics, attachment of 1,3-thiazole-4-carboxylic acid to a deprotected amine on Wang or Rink amide resin requires optimized activation. A typical standard operating procedure at 0.1 mmol scale uses 3 equivalents of the acid, 3 equivalents of HATU, and 6 equivalents of DIPEA in DMF for 45 min double-coupling cycles. Under these conditions, isolated crude purity (HPLC, 220 nm) exceeds 80%. However, if the DMF batch water content exceeds 0.1% (Karl Fischer), the active ester hydrolysis outcompetes amination, causing yields to fall to 55–70%; pre-drying molecular sieves of type 4Å restore activity. Process analytical technology (PAT) implementation using ReactIR with a diamond ATR probe has demonstrated the disappearance of the acid carbonyl peak at 1695 cm⁻¹ and the emergence of the active ester carbonyl at 1810 cm⁻¹ within 8 min at 20°C, providing a real-time endpoint control to avoid prolonged reaction that invites diketopiperazine formation from peptidyl-resin substrates.
A documented failure mode in large-scale SPPS (solid-phase peptide synthesis) involves the use of the 2-isomer inadvertently due to supplier mislabeling. The 2-carboxylic acid, once coupled, places the thiazole ring in a reverse orientation that abrogates the required hydrogen-bonding pattern with a target protease S1 pocket; this misincorporation was identified during a campaign for a clinical candidate when the IC₅₀ shifted from 12 nM to 980 nM. Identity testing via 13C NMR (carbonyl shift difference of approximately 3 ppm between 2- and 4-isomers) is thus mandatory before charging. For solution-phase amidation, switching from DMF to 2-methyltetrahydrofuran (2-MeTHF) as a greener solvent reduced the reaction time from 6 h to 3.5 h at 40°C while maintaining conversion above 95%, according to a published solvent screen utilizing DOE factorial design with three center-point replicates.
The compound’s usage also extends to the synthesis of heterocyclic metal-organic frameworks (MOFs) where the 4-carboxylate serves as a bridging ligand with copper(II) or zinc(II) nodes. In these applications, the crystal growth solution must be maintained at pH 4.5–5.0 using acetate buffer; outside this window, either protonation of the carboxylate or formation of metal hydroxide precipitates inhibits framework assembly. A 2022 report on HKUST-1 analogue structures documented that thiazole-4-carboxylate-based frameworks exhibit CO₂ adsorption capacities of 2.8 mmol·g⁻¹ at 298 K and 1 bar, lower than the parent trimesic acid framework, but with a calculated isosteric heat of adsorption 12 kJ·mol⁻¹ higher, indicating stronger binding sites due to the polarizable sulfur atom.
For medicinal chemistry applications, the compound is routinely converted to the corresponding hydrazide or hydroxamic acid to serve as a zinc-binding group in matrix metalloproteinase inhibitors. The conversion proceeds through the methyl ester (CAS 59434-20-3), obtained by treatment with thionyl chloride in methanol at 0°C to reflux, followed by hydrazinolysis. The methyl ester has a boiling point of 95–100°C at 0.5 mmHg and is more practical for storage in tropical climates where the free acid’s hygroscopic nature can elevate water content above specification within 48 h when relative humidity exceeds 60%. Precautions against electrostatic discharge are required when handling the finely divided powder in non-conductive containers; a minimum ignition energy of 10–30 mJ is estimated based on particle size distribution data, necessitating grounding and bonding per IEC 60079-32-2.
Standards, Regulatory Crosswalk, and Batch Release Criteria
The table below summarizes the main documentary standards applied during batch release and regulatory filing for 1,3-thiazole-4-carboxylic acid used as a registered starting material under a US DMF or EU ASMF. These reflect actual specifications cross-referenced across multiple pharmacopoeial and ISO frameworks. No single monograph for this exact compound exists in Ph.Eur. or USP; however, the test methodologies align with general chapters.
| Test | Method/Source | Acceptance Criterion |
|---|---|---|
| Identification (IR) | Ph.Eur. 2.2.24, USP 〈197K〉 | Concordant with reference spectrum, peaks at 1695 cm⁻¹, 1520 cm⁻¹ |
| Assay (HPLC) | In-house, validated per ICH Q2(R1) | 98.0–102.0% on anhydrous basis |
| Water content | USP 〈921〉 Method Ic, Karl Fischer | ≤ 0.5% |
| Residue on ignition | Ph.Eur. 2.4.14 | ≤ 0.1% |
| Heavy metals | USP 〈231〉 (or 〈233〉 for individual elements) | As Pb: ≤ 20 ppm; Cd ≤ 5 ppm, Hg ≤ 3 ppm |
| Residual solvents | USP 〈467〉 Procedure A, ICH Q3C | Class 2 solvents within Option 1 limits |
| Particle size (if specified) | Laser diffraction per ISO 13320:2020 | D90 ≤ 150 µm |
| Endotoxins (GMP grade) | Ph.Eur. 2.6.14 | < 0.05 EU·mg⁻¹ |
| Storage condition | Stability data generated per ICH Q1A(R2) | 2–8°C, under argon, retest period 36 months |
Differences from related carboxylic acids become most apparent under regulatory scrutiny. The 2-isomer, for instance, is classified as a combustible solid with a lower flash point (88°C closed cup, compared to > 200°C for the 4-isomer), which imposes stricter magazining requirements under local fire codes. The 5-isomer’s higher susceptibility to decarboxylation generates a volatile byproduct (thiazole) that can pressurize sealed reaction vessels if not continuously vented; process safety studies require an emergency relief system sizing per API 520 Part I for any scale exceeding 50 L. These operational boundary conditions highlight why the 4-carboxylic acid is often the preferred regioisomer when a heterocyclic building block must survive multi-step sequences with harsh heating or strong base exposure—conditions that lead to ring degradation or rapid decarboxylation in the 2- and 5-substituted analogues.
Where published data for this specific configuration are limited, particularly in the context of continuous flow telescoped syntheses, early adopter protocol transfers have demonstrated that a plug flow reactor equipped with a 1/8-inch OD PTFE coil operating at 120°C and 15 min residence time can execute the ester hydrolysis of the corresponding nitrile (4-cyanothiazole) selectively without the need for isolation of the intermediate amide. However, the risk of forming thiazole-4-carboxamide as a persistent impurity that carries through into the final API step is acknowledged in the literature, and the specification for that impurity in the purified acid stage is set at ≤ 0.15% by a dedicated ion-pair HPLC method with a LOD of 0.02%.